Multiple Sclerosis Trial, Recruiting (NCT00001975)

Multiple Sclerosis Trial, Recruiting NCT00001975 Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT00001975 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Tuberous Sclerosis Complex (TSC) — either confirmed, probable, or possible — based on medical tests or genetic testing
You are between 18 and 90 years old
Your TSC diagnosis may be based on having certain major signs of the condition, such as skin growths on the face, unusual skin patches, tumors in the eyes, brain, heart, or kidneys, or lung problems (confirm with trial site for full details)
Your TSC diagnosis may also be based on having a combination of smaller, less definitive signs of the condition, such as dental pits, bowel growths, bone cysts, or certain skin markings (confirm with trial site for full details)
You do not need to have skin lesions to take part, though most people with TSC do

Who may not be able to join:

You are not able to give your own informed consent to participate
You have a tendency to form raised, overgrown scars (called keloids) after skin injury
You have a known allergy to anaesthetics (numbing medications)
You have a condition that affects your blood's ability to clot normally or you bleed more than usual

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joel Moss, M.D., National Heart, Lung, and Blood Institute (NHLBI)

Phone: (301) 827-1376

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00001975

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: (301) 827-1376

More information: https://clinicaltrials.gov/study/NCT00001975

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Tuberous Sclerosis Complex (TSC) — either confirmed, probable, or possible — based on medical tests or genetic testing
You are between 18 and 90 years old
Your TSC diagnosis may be based on having certain major signs of the condition, such as skin growths on the face, unusual skin patches, tumors in the eyes, brain, heart, or kidneys, or lung problems (confirm with trial site for full details)
Your TSC diagnosis may also be based on having a combination of smaller, less definitive signs of the condition, such as dental pits, bowel growths, bone cysts, or certain skin markings (confirm with trial site for full details)
You do not need to have skin lesions to take part, though most people with TSC do

Who may not be able to join:

You are not able to give your own informed consent to participate
You have a tendency to form raised, overgrown scars (called keloids) after skin injury
You have a known allergy to anaesthetics (numbing medications)
You have a condition that affects your blood's ability to clot normally or you bleed more than usual

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Registry

ClinicalTrials.gov

Start date

26 January 2000

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

1.Identify the tumor cells in cutaneous and mucosal tumors in patients with TSC through LOH studies on microdissected cell populations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov